Literature DB >> 9804960

The expression of the Leishmania infantum KMP-11 protein is developmentally regulated and stage specific.

C Berberich1, G Machado, G Morales, G Carrillo, A Jiménez-Ruiz, C Alonso.   

Abstract

Transcription of the gene coding for the KMP-11 protein of Leishmania infantum results in the production of a mature RNA transcript of 1.3 kb in length. The expression of KMP-11 mRNA is strongly down-regulated not only during the parasite growth from the logarithmic to the stationary phase but also during the differentiation transit from promastigotes to amastigotes. The estimated concentration of KMP-11 is one order of magnitude higher in promastigotes than in amastigotes. The analysis of the Triton X-114 phase partition of the protein shows that, in agreement with its predicted secondary structure, KMP-11 has an amphipathic nature since it is found in the aqueous as well as in the detergent phase. By fluorescence microscopy a defined pattern of distribution of the protein was observed only in promastigotes where KMP-11 is mainly located in the flagellum and the flagellar pocket.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804960     DOI: 10.1016/s0167-4781(98)00176-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

Authors:  Felicitat Todolí; Laia Solano-Gallego; Rafael de Juan; Pere Morell; Maria Del Carmen Núñez; Rodrigo Lasa; Silvia Gómez-Sebastián; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

2.  KMP-11, a basal body and flagellar protein, is required for cell division in Trypanosoma brucei.

Authors:  Ziyin Li; Ching C Wang
Journal:  Eukaryot Cell       Date:  2008-09-26

3.  Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.

Authors:  Tobias Hanke; María J Ramiro; Sonia Trigueros; Joaquim Roca; Vicente Larraga
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

Review 4.  The eukaryotic flagellum makes the day: novel and unforeseen roles uncovered after post-genomics and proteomics data.

Authors:  Michely C Diniz; Ana Carolina L Pacheco; Kaio M Farias; Diana M de Oliveira
Journal:  Curr Protein Pept Sci       Date:  2012-09       Impact factor: 3.272

Review 5.  Global distribution of treatment resistance gene markers for leishmaniasis.

Authors:  Samira Salari; Mehdi Bamorovat; Iraj Sharifi; Pooya Ghasemi Nejad Almani
Journal:  J Clin Lab Anal       Date:  2022-07-09       Impact factor: 3.124

6.  Combining RNA interference mutants and comparative proteomics to identify protein components and dependences in a eukaryotic flagellum.

Authors:  Neil Portman; Sylvain Lacomble; Benjamin Thomas; Paul G McKean; Keith Gull
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  Identification of a novel chromosomal passenger complex and its unique localization during cytokinesis in Trypanosoma brucei.

Authors:  Ziyin Li; Ju Huck Lee; Feixia Chu; Alma L Burlingame; Arthur Günzl; Ching C Wang
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

Review 8.  Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania.

Authors:  Sergio Coutinho Furtado de Mendonça; Léa Cysne-Finkelstein; Denise Cristina de Souza Matos
Journal:  Front Immunol       Date:  2015-10-13       Impact factor: 7.561

9.  Humoral Responses and Ex Vivo IFN-γ Production after Canine Whole Blood Stimulation with Leishmania infantum Antigen or KMP11 Recombinant Protein.

Authors:  Pamela Martínez-Orellana; Noemí González; Antonella Baldassarre; Alejandra Álvarez-Fernández; Laura Ordeix; Paola Paradies; Manuel Soto; Laia Solano-Gallego
Journal:  Vet Sci       Date:  2022-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.